OTLK
OTLK
NASDAQ · Biotechnology

Outlook Therapeutics Inc

$0.62
-0.02 (-2.88%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +5,499.7% upside
Low Target $27.07
Average Target $34.78
High Target $51.13
Current Price $0.62
Current
$0.62
Target
$34.78
$27.07 $34.78 avg $51.13
Scenario Analysis
Bear Case
$27.07
4,258.4%
Low target
Base Case
$34.78
+5,499.7%
Avg target
Bull Case
$51.13
+8,132.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.54
-75.5% from high
52-Week Low
$0.16
+285.5% from low
Target vs 52W High
$34.78
+1,270.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%